These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18493606)

  • 1. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer.
    Yang Y; Iwanaga K; Raso MG; Wislez M; Hanna AE; Wieder ED; Molldrem JJ; Wistuba II; Powis G; Demayo FJ; Kim CF; Kurie JM
    PLoS One; 2008 May; 3(5):e2220. PubMed ID: 18493606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation.
    Regala RP; Justilien V; Walsh MP; Weems C; Khoor A; Murray NR; Fields AP
    PLoS One; 2011; 6(10):e26439. PubMed ID: 22022614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.
    Dovey JS; Zacharek SJ; Kim CF; Lees JA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11857-62. PubMed ID: 18697930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.
    Iwanaga K; Yang Y; Raso MG; Ma L; Hanna AE; Thilaganathan N; Moghaddam S; Evans CM; Li H; Cai WW; Sato M; Minna JD; Wu H; Creighton CJ; Demayo FJ; Wistuba II; Kurie JM
    Cancer Res; 2008 Feb; 68(4):1119-27. PubMed ID: 18281487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of bronchioalveolar stem cells in normal lung and lung cancer.
    Kim CF; Jackson EL; Woolfenden AE; Lawrence S; Babar I; Vogel S; Crowley D; Bronson RT; Jacks T
    Cell; 2005 Jun; 121(6):823-35. PubMed ID: 15960971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
    Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
    Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.
    Yanagi S; Kishimoto H; Kawahara K; Sasaki T; Sasaki M; Nishio M; Yajima N; Hamada K; Horie Y; Kubo H; Whitsett JA; Mak TW; Nakano T; Nakazato M; Suzuki A
    J Clin Invest; 2007 Oct; 117(10):2929-40. PubMed ID: 17909629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.
    Mainardi S; Mijimolle N; Francoz S; Vicente-Dueñas C; Sánchez-García I; Barbacid M
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):255-60. PubMed ID: 24367082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38α negatively regulates survival and malignant selection of transformed bronchioalveolar stem cells.
    Voisset E; Oeztuerk-Winder F; Ruiz EJ; Ventura JJ
    PLoS One; 2013; 8(11):e78911. PubMed ID: 24265727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.
    Micucci C; Orciari S; Catalano A
    PLoS One; 2014; 9(8):e105550. PubMed ID: 25144301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2.
    Xu X; Huang L; Futtner C; Schwab B; Rampersad RR; Lu Y; Sporn TA; Hogan BL; Onaitis MW
    Genes Dev; 2014 Sep; 28(17):1929-39. PubMed ID: 25184679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar type II cells possess the capability of initiating lung tumor development.
    Lin C; Song H; Huang C; Yao E; Gacayan R; Xu SM; Chuang PT
    PLoS One; 2012; 7(12):e53817. PubMed ID: 23285300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
    Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H
    Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
    Pan Y; Jiang Y; Tan L; Ravoori MK; Gagea M; Kundra V; Fischer SM; Yang P
    Oncotarget; 2015 Nov; 6(36):38816-26. PubMed ID: 26452035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
    Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW
    PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma.
    Yin H; Jing B; Xu D; Guo W; Sun B; Zhang J; Liao Y; Song H; Wang T; Liu S; Kuang Y; Hu M; Li K; Zhang S; Zhang H; Xu J; Li X; Du J; Wu Y; Wu Y; Wang Q; Yao F; Chin YE; Zhou BP; Deng J
    Cancer Res; 2022 Mar; 82(6):1025-1037. PubMed ID: 35045987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.
    Gibbons DL; Lin W; Creighton CJ; Zheng S; Berel D; Yang Y; Raso MG; Liu DD; Wistuba II; Lozano G; Kurie JM
    PLoS One; 2009; 4(4):e5401. PubMed ID: 19404390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic surface-enhanced Raman spectroscopic (M-SERS) dots for the identification of bronchioalveolar stem cells in normal and lung cancer mice.
    Noh MS; Jun BH; Kim S; Kang H; Woo MA; Minai-Tehrani A; Kim JE; Kim J; Park J; Lim HT; Park SC; Hyeon T; Kim YK; Jeong DH; Lee YS; Cho MH
    Biomaterials; 2009 Aug; 30(23-24):3915-25. PubMed ID: 19411103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.
    Degrassi A; Russo M; Nanni C; Patton V; Alzani R; Giusti AM; Fanti S; Ciomei M; Pesenti E; Texido G
    Mol Cancer Ther; 2010 Mar; 9(3):673-81. PubMed ID: 20197397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.